相关实验视频

Updated: Jun 23, 2025

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Published on: January 16, 2015

缺氧使EZH2抑制剂不容易-HIF和EZH2之间交叉的进展

Zhanya Huang^1,2, Yuanjun Tang², Jianlin Zhang²

¹Cancer Center of Peking University Third Hospital, Beijing 100191, China.

Life metabolism

|June 24, 2024

概括

增强性凝血同类2 (EZH2) 抑制剂对固体瘤显示有前途. 针对EZH2和缺氧诱导因子1-alpha (HIF-1α) 之间的相互作用,可以克服缺氧瘤的治疗阻力.

科学领域:

表观遗传学和癌症生物学
瘤微环境研究研究

背景情况:

基斯甲基化是癌症发展的组成部分.
增强质同源2 (EZH2) 调节基因表达和染色质结构.
EZH2抑制剂 (EZH2is) 在血液癌症中有效,但在固体瘤中有限.

研究的目的:

探索EZH2-低氧轴在固体瘤进展中的作用.
讨论提高EZH2抑制剂在固体瘤中的疗效的策略.
研究缺氧诱导因子1-alpha (HIF-1α) 对癌症中EZH2功能的影响.

主要方法:

对EZH2,缺氧和固体瘤生物学现有文献的综述.
分析EZH2和HIF-1α信号通路之间的相互作用.
对低氧固体瘤中EZH2抑制剂的潜在治疗影响的讨论.

主要成果:

缺氧瘤微环境对EZH2抑制剂治疗构成重大挑战.
低氧诱导因子1-α (HIF-1α) 与EZH2相互作用,促进瘤的进展.
了解EZH2-低氧关系对于改善固体瘤治疗至关重要.

结论:

针对EZH2和HIF-1α之间的相互作用提供了一个潜在的治疗途径.
开发克服缺氧介导抗性的策略可以扩大EZH2抑制剂的应用.
需要进一步的研究来将这些发现转化为有效的固体瘤治疗方法.

关键词:

在 EZH2 中使用.这就是HIF-1α.在TCA循环中,TCA循环是药物组合是药物组合.缺氧缺氧是指缺氧的情况.纳米颗粒是一种纳米粒子.

更多相关视频

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Chromatin Modification in iPS Cells

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...

Spreading of Chromatin Modifications

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...

Histone Variants at the Centromere

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...

Position-effect Variegation

Position-effect Variegation

In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...